LNK (SH2B3): paradoxical effects in ovarian cancer

Integrated genomic analyses of ovarian carcinoma

Debra Bell, Andrew Berchuck, Wendy Winckler · Nature · 2011 · 8K citations · Full text

Tumor Heterogeneity, Gynecology, Cancer Genomics +3

Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia

Kathryn G. Roberts, Ryan D. Morin, Jinghui Zhang et al. · Cancer Cell · 2012 · 699 citations · Full text

Hematological Malignancy, Cell Signaling, Malignant Blood Disorder +9

JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin

Mark A. Dawson, Andrew J. Bannister, Berthold Göttgens et al. · Nature · 2009 · 600 citations

Histone Modifications, Chromatin, Transcriptional Regulation +12

The landscape of somatic mutations in Down syndrome–related myeloid disorders

Kenichi Yoshida, Tsutomu Toki, Yusuke Okuno et al. · Nature Genetics · 2013 · 381 citations

Down Syndrome, Somatic Variant, Somatic Mutations +7

Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms

Stephen T. Oh, Erin F. Simonds, Carol D. Jones et al. · Blood · 2010 · 319 citations · Full text